|
SYT11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.139200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.070600E-01 |
| Normal-vs-Stage2 |
5.435600E-01 |
| Normal-vs-Stage3 |
5.262600E-01 |
| Normal-vs-Stage4 |
4.641000E-01 |
| Stage1-vs-Stage2 |
9.828200E-01 |
| Stage1-vs-Stage3 |
5.727500E-02 |
| Stage1-vs-Stage4 |
9.594200E-02 |
| Stage2-vs-Stage3 |
2.859200E-01 |
| Stage2-vs-Stage4 |
2.550000E-01 |
| Stage3-vs-Stage4 |
8.261200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.505000E-01 |
| Normal-vs-AfricanAmerican |
9.999200E-01 |
| Normal-vs-Asian |
2.451400E-01 |
| Caucasian-vs-AfricanAmerican |
9.091600E-01 |
| Caucasian-vs-Asian |
2.502000E-01 |
| AfricanAmerican-vs-Asian |
2.487200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.144600E-01 |
| Normal-vs-Female |
3.159600E-01 |
| Male-vs-Female |
1.721970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.674400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.306000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.417000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.371600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.252800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.565380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.377600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.340400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.208000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.471600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.485700E-02 |
| Normal-vs-Grade 2 |
1.408640E-01 |
| Normal-vs-Grade 3 |
5.053600E-01 |
| Normal-vs-Grade 4 |
6.993000E-01 |
| Grade 1-vs-Grade 2 |
3.017600E-01 |
| Grade 1-vs-Grade 3 |
2.823900E-02 |
| Grade 1-vs-Grade 4 |
8.708500E-02 |
| Grade 2-vs-Grade 3 |
9.241700E-03 |
| Grade 2-vs-Grade 4 |
1.108760E-01 |
| Grade 3-vs-Grade 4 |
8.852800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.648800E-01 |
| Normal-vs-ccB subtype |
6.454400E-01 |
| ccA subtype-vs-ccB subtype |
5.756800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.442200E-01 |
| Normal-vs-N1 |
8.179400E-01 |
| N0-vs-N1 |
9.620400E-01 |
|
|
